Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- BOT.AU
- Price
- 0.42
- Stock movement down
- -0.01 (-3.41%)
- Company name
- Botanix Pharmaceuticals Ltd
- Exchange
- (AU ,
- Currency
- AUD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 772.49M
- Ent value
- 696.92M
- Price/Sales
- 314.80
- Price/Book
- 7.10
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -16.30%
- 1 year return
- 88.89%
- 3 year return
- 78.68%
- 5 year return
- 74.86%
- 10 year return
- 21.77%
Last updated: 2025-04-04
DIVIDENDS
BOT.AU does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 314.80 |
| Price to Book | 7.10 |
| EV to Sales | 284.00 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 1.82B |
| EPS (TTM) | -0.01 |
| FCF per share (TTM) | -0.02 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 2.45M |
| Gross profit (TTM) | -6.48M |
| Operating income (TTM) | -21.13M |
| Net income (TTM) | -20.71M |
| EPS (TTM) | -0.01 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | -264.14% |
| Operating margin (TTM) | -861.02% |
| Profit margin (TTM) | -843.76% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 79.31M |
| Net receivables | 817.04K |
| Total current assets | 82.90M |
| Goodwill | 0.00 |
| Intangible assets | 29.49M |
| Property, plant and equipment | 71.78K |
| Total assets | 112.46M |
| Accounts payable | 2.73M |
| Short/Current long term debt | 0.00 |
| Total current liabilities | 3.73M |
| Total liabilities | 3.73M |
| Shareholder's equity | 108.73M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -17.64M |
| Capital expenditures (TTM) | 16.79M |
| Free cash flow (TTM) | -34.44M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -19.04% |
| Return on Assets | -18.41% |
| Return on Invested Capital | -19.04% |
| Cash Return on Invested Capital | -31.67% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 0.43 |
| Daily high | 0.44 |
| Daily low | 0.41 |
| Daily Volume | 6.31M |
| All-time high | 3687.20 |
| 1y analyst estimate | 0.65 |
| Beta | 1.87 |
| EPS (TTM) | -0.01 |
| Dividend per share | - |
| Ex-div date | 3 Oct 1996 |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| BOT.AU | S&P500 | |
| Current price drop from All-time high | -99.99% | -12.44% |
| Highest price drop | -100.00% | -56.47% |
| Date of highest drop | 16 Dec 2014 | 9 Mar 2009 |
| Avg drop from high | -85.97% | -11.07% |
| Avg time to new high | 140 days | 12 days |
| Max time to new high | 5731 days | 1805 days |
COMPANY DETAILS
Marketcap
772.49M
Marketcap category
Small-cap
Description
Botanix Pharmaceuticals Limited engages in the research and development of dermatology and antimicrobial products in Australia and the United States. Its product pipeline includes Sofpironium Bromide, a drug in development for the treatment of primary axillary hyperhidrosis that has completed Phase 3 clinical programs; BTX 1503, a transdermal gel formulation for the treatment of serious acne in adults and teenagers that has completed Phase II clinical trials; BTX 1801, which has completed Phase IIa clinical trials for the treatment of staphylococcus aureus and methicillin resistant staphylococcus aureus; BTX 1702 that is in Phase II clinical trials for the treatment of papulopustular rosacea; and BTX 1204A for the treatment of atopic dermatitis. Botanix Pharmaceuticals Limited was incorporated in 1984 and is based in West Perth, Australia.
Employees
0
Investor relations
-
SEC filings
CEO
Country
Australia
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found